IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.822
EU - Europa 7.934
AS - Asia 5.036
Continente sconosciuto - Info sul continente non disponibili 30
SA - Sud America 5
OC - Oceania 4
AF - Africa 3
Totale 21.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.790
CN - Cina 1.954
UA - Ucraina 1.850
IE - Irlanda 1.538
TR - Turchia 1.390
SG - Singapore 1.362
SE - Svezia 960
GB - Regno Unito 813
IT - Italia 753
FR - Francia 620
DE - Germania 598
FI - Finlandia 389
RU - Federazione Russa 292
IN - India 280
CZ - Repubblica Ceca 34
EU - Europa 26
CA - Canada 22
PL - Polonia 17
BE - Belgio 15
AT - Austria 14
IL - Israele 12
IR - Iran 12
NL - Olanda 9
VN - Vietnam 6
RO - Romania 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BZ - Belize 4
LT - Lituania 4
MX - Messico 4
DK - Danimarca 3
HK - Hong Kong 3
JP - Giappone 3
RS - Serbia 3
AU - Australia 2
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
ES - Italia 2
GR - Grecia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
TH - Thailandia 1
VE - Venezuela 1
Totale 21.834
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.153
Dublin 1.529
Chandler 1.452
Singapore 1.191
Princeton 744
Izmir 730
Southend 656
Nanjing 603
Wilmington 383
Cambridge 340
Ashburn 306
Santa Clara 302
Beijing 299
Dearborn 298
Altamura 295
Nanchang 224
Ann Arbor 164
Chieti 124
Boardman 111
Hebei 103
Shenyang 103
Woodbridge 101
Tianjin 91
Kunming 88
Jiaxing 69
Washington 69
Grevenbroich 67
New York 67
Los Angeles 66
Moscow 64
Norwalk 56
Helsinki 55
Changsha 53
Munich 36
Hangzhou 35
Augusta 31
Orange 31
Brno 28
Jinan 28
Changchun 27
Lanzhou 26
San Mateo 25
Ningbo 22
Houston 20
Falls Church 19
Seattle 19
Leawood 18
Toronto 18
Pescara 17
Shanghai 17
Rome 16
Brussels 15
Zhengzhou 13
Frankfurt am Main 11
Guangzhou 11
Haikou 10
Hefei 10
Auburn Hills 9
Cedar Knolls 8
Fuzhou 8
Pune 8
Tappahannock 8
Andover 7
Meylan 7
Bologna 6
Caserta 6
Dong Ket 6
Edinburgh 6
Milan 6
Simi Valley 6
Taiyuan 6
Walnut 6
Düsseldorf 5
London 5
Mountain View 5
Perugia 5
Romola 5
Saint-prix 5
Taipei 5
Taizhou 5
Wuhan 5
Catania 4
Chengdu 4
Chongqing 4
Kraków 4
Lanciano 4
Naples 4
Palermo 4
Paris 4
Radomsko 4
Secaucus 4
Torino 4
Anzola Dell'emilia 3
Ardabil 3
Bassano Del Grappa 3
Belgrade 3
Clifton 3
Hanover 3
Harbin 3
Kocaeli 3
Totale 13.675
Salva come PNG Salva come JPEG
Nome #
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 139
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 126
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 124
Pentraxin 3 and platelet activation in obese patients after gastric banding 123
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 121
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 117
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 117
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 115
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 115
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 113
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 113
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 110
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 105
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 105
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 104
Platelets and Diabetes 104
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 102
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 100
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 100
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 100
Determinants of platelet activation in hypertensives with microalbuminuria. 98
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 98
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 98
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 98
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 97
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 97
Platelets and diabetes mellitus 97
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 96
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 95
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 95
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 95
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 94
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 94
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 93
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 92
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 92
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 92
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 90
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 90
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 90
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 89
Platelet activation in obesity and metabolic syndrome. 89
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 89
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 89
Coagulation and infective endocarditis: sooner or later 89
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 88
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 88
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 87
Atherothrombotic disease and the metabolic syndrome. 87
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 87
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 86
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 86
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 86
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 86
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 86
A comparison of five maintenance therapies for reflux esophagitis 85
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 85
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 85
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 84
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 84
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 84
Antipsychotic prescription and mortality in hospitalized older persons 84
Increased soluble CD40L levels in cystic fibrosis 83
Endothelial dysfunction and oxidative stress in arterial hypertension. 83
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 83
Soluble forms of RAGE in internal medicine. 83
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 82
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 82
Insulin resistance as a determinant of platelet activation in obese women. 81
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 81
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 81
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 81
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 80
Homocysteine modulates the CD40/CD40L system 80
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 80
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 80
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 79
Increased levels of soluble P-selectin in hypercholesterolemic patients 79
Leptin increase is associated with markers of the hemostatic system in obese healthy women 79
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 79
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 78
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 78
Soluble RAGE in type 2 diabetes: association with oxidative stress. 78
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
Determinants of platelet activation in hypertensives with microalbuminuria. 77
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity. 77
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 76
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 76
Diabetes mellitus and thrombosis 76
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 76
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 75
What do we know about obesity? 75
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 74
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 74
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 73
Aterosclerosi ed aterosclerosi accelerata: ruolo e meccanismi dell’immunoflogosi. 73
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 73
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 73
Association between serum leptin levels and 24-hour blood pressure in obese women. 73
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 72
Totale 9.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.037 0 0 0 0 0 0 532 470 117 428 466 24
2020/20212.055 391 12 386 11 120 487 24 20 157 326 39 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.428 432 654 236 425 385 931 302 299 529 45 97 93
2023/20241.949 139 78 136 50 118 633 504 72 18 33 14 154
2024/20252.693 463 1.089 862 67 77 134 1 0 0 0 0 0
Totale 22.931